Background: New Psychoactive Substances (NPS) constitute a broad range of hundreds of natural and synthetic drugs, including synthetic opioids, synthetic cannabinoids, synthetic cathinones, and other NPS classes, which were not controlled from 1961 to 1971 by the United Nations drug control conventions. Among these, synthetic opioids represent a major threat to public health. Methods: A literature search was carried out using public databases (such as PubMed, Google Scholar, and Scopus) to survey fentanyl-, fentanyl analogs-, and other synthetic opioid-related deaths. Keywords including “fentanyl”, “fentanyl analogs”, “death”, “overdose”, “intoxication”, “synthetic opioids”, “Novel Psychoactive Substances”, “MT-45”, “AH-7921”, and “U-47700” were used for the inquiry. Results: From our literature examination, we inferred the frequent implication of fentanyls and synthetic opioids in side effects, which primarily affected the central nervous system and the cardiovascular and pulmonary systems. The data showed a great variety of substances and lethal concentrations. Multidrug-related deaths appeared very common, in most reported cases. Conclusions: The investigation of the contribution of novel synthetic opioid intoxication to death should be based on a multidisciplinary approach aimed at framing each case and directing the investigation towards targeted toxicological analyses.
In the recent decade, numerous new psychoactive substances (NPSs) have been added to the illicit drug market. These are synthetized to mimic the effects of classic drugs of abuse (i.e., cannabis, cocaine, etc.), with the purpose of bypassing substance legislations and increasing the pharmacotoxicological effects. To date, research into the acute pharmacological effects of new NPSs is ongoing and necessary in order to provide an appropriate contribution to public health. In fact, multiple examples of NPS-related acute intoxication and mortality have been recorded in the literature. Accordingly, several in vitro and in vivo studies have investigated the pharmacotoxicological profiles of these compounds, revealing that they can cause adverse effects involving various organ systems (i.e., cardiovascular, respiratory effects) and highlighting their potential increased consumption risks. In this sense, NPSs should be regarded as a complex issue that requires continuous monitoring. Moreover, knowledge of long-term NPS effects is lacking. Because genetic and environmental variables may impact NPS responses, epigenetics may aid in understanding the processes behind the harmful events induced by long-term NPS usage. Taken together, “pharmacoepigenomics” may provide a new field of combined study on genetic differences and epigenetic changes in drug reactions that might be predictive in forensic implications.
Background: Novel Synthetic Opioids (NSOs) currently represent the third most prevalent group among New Psychoactive Substances (NPS), yet they represent the category associated with the highest health risk. Their extreme pharmacological potency compared to traditional opioids, coupled with structural heterogeneity and low concentrations in biological matrices, poses significant analytical challenges for detection. Methods: This study proposes an indirect screening approach based on untargeted metabolomics to monitor systemic responses following brorphine administration. Urinary metabolic profiling was conducted using a sex-balanced murine cohort (n = 10); metabolic profile variations were analyzed following acute and repeated administrations. Samples were collected at 0–12 h and 12–24 h intervals and analyzed by liquid chromatography coupled with high resolution mass spectrometry (LC-HRMS); data were processed using ANOVA–Simultaneous Component Analysis (ASCA), for the isolation of metabolic fingerprints associated with distinct experimental factors (sex, treatment, sampling time). Results: The results revealed a notable metabolic divergence upon repeated administration, linked to sexual diergism: while females exhibited a high recovery capacity supported by a more efficient metabolic biotransformation, males showed a stronger energetic deficit, likely due to greater substance persistence and accumulation. Male vulnerability is characterized by neuro-metabolic dysfunction, inhibition of γ-aminobutyric acid (GABA) release and altered dopaminergic turnover. This systemic imbalance is further defined by massive amino acid and nucleotide catabolism, alongside an energetic deficit exacerbated by inefficient β-oxidation. Conclusions: This study demonstrates that metabolomics may provide interesting insights for the study of NPS by recognizing the biochemical signatures of drug consumption and it is essential for developing sex-specific strategies within the broader context of opioid pharmacology.